Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim P Buttery

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The Medical Journal of Australia|November 13, 2014
The safety of seasonal influenza vaccines in Australian children in 2013Nicholas J Wood, Chris C Blyth, Gabriela A Willis, et al.
The Medical Journal of Australia|December 10, 2024
Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional studyJulia Smith, Silja Schrader, Hannah Morgan, et al.
Vaccine|February 29, 2020
The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018Christopher C Blyth, Allen C Cheng, Nigel W Crawford, et al.
The Pediatric Infectious Disease Journal|December 20, 2012
Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in AustraliaHelen S Marshall, Peter McIntyre, Peter Richmond, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infantsClare L Collins, Jens U Ruggeberg, Gail Balfour, et al.
The Lancet. Infectious Diseases|August 31, 2015
Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trialJulie E Bines, Margaret Danchin, Pamela Jackson, et al.
Human Vaccines & Immunotherapeutics|April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccinesSally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
The Pediatric Infectious Disease Journal|October 1, 2021
Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income CountriesGabriella Watson, Caitlin Dodd, Flor M Munoz, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Medical Journal of Australia|November 13, 2014
The safety of seasonal influenza vaccines in Australian children in 2013Nicholas J Wood, Chris C Blyth, Gabriela A Willis, et al.
The Medical Journal of Australia|December 10, 2024
Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional studyJulia Smith, Silja Schrader, Hannah Morgan, et al.
Vaccine|February 29, 2020
The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018Christopher C Blyth, Allen C Cheng, Nigel W Crawford, et al.
The Pediatric Infectious Disease Journal|December 20, 2012
Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in AustraliaHelen S Marshall, Peter McIntyre, Peter Richmond, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infantsClare L Collins, Jens U Ruggeberg, Gail Balfour, et al.
The Lancet. Infectious Diseases|August 31, 2015
Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trialJulie E Bines, Margaret Danchin, Pamela Jackson, et al.
Human Vaccines & Immunotherapeutics|April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccinesSally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
The Pediatric Infectious Disease Journal|October 1, 2021
Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income CountriesGabriella Watson, Caitlin Dodd, Flor M Munoz, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 10